{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:13:41Z","timestamp":1794348821356,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM034496"],"award-info":[{"award-number":["GM034496"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CoA Therapeutics"},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pantothenate kinase (PANK) is the first and rate-controlling enzymatic step in the only pathway for cellular coenzyme A (CoA) biosynthesis. PANK-associated neurodegeneration (PKAN), formerly known as Hallervorden\u2013Spatz disease, is a rare, life-threatening neurologic disorder that affects the CNS and arises from mutations in the human <jats:italic>PANK2<\/jats:italic> gene. Pantazines, a class of small molecules containing the pantazine moiety, yield promising therapeutic effects in an animal model of brain CoA deficiency. A reliable technique to identify the neurometabolic effects of PANK dysfunction and to monitor therapeutic responses is needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We applied <jats:sup>1<\/jats:sup>H magnetic resonance spectroscopy as a noninvasive technique to evaluate the therapeutic effects of the newly developed Pantazine BBP-671.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:sup>1<\/jats:sup>H MRS reliably quantified changes in cerebral metabolites, including glutamate\/glutamine, lactate, and N-acetyl aspartate in a neuronal <jats:italic>Pank1 and Pank2<\/jats:italic> double-knockout (<jats:italic>SynCre<\/jats:italic><jats:sup>+<\/jats:sup><jats:italic>Pank1,2<\/jats:italic> dKO) mouse model of brain CoA deficiency. The neuronal <jats:italic>SynCre<\/jats:italic><jats:sup>+<\/jats:sup><jats:italic>Pank1,2<\/jats:italic> dKO mice had distinct decreases in Glx\/tCr, NAA\/tCr, and lactate\/tCr ratios compared to the wildtype matched control mice that increased in response to BBP-671 treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>BBP-671 treatment completely restored glutamate\/glutamine levels in the brains of the mouse model, suggesting that these metabolites are promising clinically translatable biomarkers for future therapeutic trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03304-y","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:03:20Z","timestamp":1645621400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proton magnetic resonance spectroscopy detects cerebral metabolic derangement in a mouse model of brain coenzyme a deficiency"],"prefix":"10.1186","volume":"20","author":[{"given":"Yanan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zane","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Patay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Akers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles O.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Jackowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2264-2341","authenticated-orcid":false,"given":"Puneet","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"3304_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.plipres.2005.04.001","volume":"44","author":"R Leonardi","year":"2005","unstructured":"Leonardi R, Zhang Y-M, Rock CO, Jackowski S. Coenzyme A: back in action. Prog Lipid Res. 2005;44:125\u201353.","journal-title":"Prog Lipid Res"},{"key":"3304_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1042\/BST20140125","volume":"42","author":"B Srinivasan","year":"2014","unstructured":"Srinivasan B, Sibon OC. Coenzyme A, more than \u2018just\u2019 a metabolic cofactor. Biochem Soc Trans. 2014;42:1075\u20139.","journal-title":"Biochem Soc Trans"},{"key":"3304_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng572","volume":"28","author":"B Zhou","year":"2001","unstructured":"Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet. 2001;28:345\u20139.","journal-title":"Nat Genet"},{"key":"3304_CR4","doi-asserted-by":"publisher","first-page":"165663","DOI":"10.1016\/j.bbadis.2020.165663","volume":"1866","author":"C Subramanian","year":"2020","unstructured":"Subramanian C, Yao J, Frank MW, Rock CO, Jackowski S. A pantothenate kinase-deficient mouse model reveals a gene expression program associated with brain coenzyme a reduction. Biochim Biophys Acta. 2020;1866:165663.","journal-title":"Biochim Biophys Acta"},{"issue":"611","key":"3304_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf5965","volume":"13","author":"C Subramanian","year":"2021","unstructured":"Subramanian C, Frank MW, Tangallapally R, Yun MK, Edwards A, White SW, Lee RE, Rock CO, Jackowski S. Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia. Sci Transl Med. 2021;13(611): eabf5965. https:\/\/doi.org\/10.1126\/scitranslmed.abf5965.","journal-title":"Sci Transl Med."},{"key":"3304_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:1\u201311.","journal-title":"Nat Commun"},{"key":"3304_CR7","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1007\/s12035-015-9567-6","volume":"53","author":"C Veyrat-Durebex","year":"2016","unstructured":"Veyrat-Durebex C, Corcia P, Piver E, Devos D, Dangoumau A, Gouel F, Vourc\u2019h, P., Emond, P., Laumonnier, F., and Nadal-Desbarats, L. Disruption of TCA cycle and glutamate metabolism identified by metabolomics in an in vitro model of amyotrophic lateral sclerosis. Mol Neurobiol. 2016;53:6910\u201324.","journal-title":"Mol Neurobiol"},{"key":"3304_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/brainsci11081031","volume":"11","author":"L Mignani","year":"2021","unstructured":"Mignani L, Gnutti B, Zizioli D, Finazzi D. Coenzyme A biochemistry: from neurodevelopment to neurodegeneration. Brain Sci. 2021;11:1031. https:\/\/doi.org\/10.3390\/brainsci11081031.","journal-title":"Brain Sci"},{"issue":"9","key":"3304_CR9","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/mds.28642","volume":"36","author":"N Thakur","year":"2021","unstructured":"Thakur N, Klopstock T, Jackowski S, Kuscer E, Tricta F, Videnovic A, Jinnah HA. Rational design of novel therapies for pantothenate kinase-associated neurodegeneration. Mov Disord. 2021;36(9):2005\u201316. https:\/\/doi.org\/10.1002\/mds.28642 (Epub 2021 May 18).","journal-title":"Mov Disord"},{"key":"3304_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"LK Sharma","year":"2018","unstructured":"Sharma LK, Subramanian C, Yun M-K, Frank MW, White SW, Rock CO, Lee RE, Jackowski S. A therapeutic approach to pantothenate kinase associated neurodegeneration. Nat Commun. 2018;9:1\u201315.","journal-title":"Nat Commun"},{"key":"3304_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuroimage.2011.12.038","volume":"61","author":"JM Duarte","year":"2012","unstructured":"Duarte JM, Lei H, Mlyn\u00e1rik V, Gruetter R. The neurochemical profile quantified by in vivo 1H NMR spectroscopy. Neuroimage. 2012;61:342\u201362.","journal-title":"Neuroimage"},{"key":"3304_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nm0396-323","volume":"2","author":"MC Preul","year":"1996","unstructured":"Preul MC, Caramanos Z, Collins DL, Villemure J-G, Leblanc R, Olivier A, Pokrupa R, Arnold DL. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 1996;2:323\u20135.","journal-title":"Nat Med"},{"key":"3304_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/nbm.1145","volume":"20","author":"JK Choi","year":"2007","unstructured":"Choi JK, Dedeoglu A, Jenkins BG. Application of MRS to mouse models of neurodegenerative illness. NMR Biomed. 2007;20:216\u201337.","journal-title":"NMR Biomed"},{"key":"3304_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pscychresns.2009.05.004","volume":"174","author":"S Yang","year":"2009","unstructured":"Yang S, Salmeron BJ, Ross TJ, Xi Z-X, Stein EA, Yang Y. Lower glutamate levels in rostral anterior cingulate of chronic cocaine users\u2014a 1H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy. Psychiatry Re Neuroimaging. 2009;174:171\u20136.","journal-title":"Psychiatry Re Neuroimaging"},{"key":"3304_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4081\/ni.2019.7959","volume":"11","author":"AH Habibi","year":"2019","unstructured":"Habibi AH, Razmeh S, Aryani O, Rohani M, Taghavian L, Alizadeh E, Moradian Kokhedan K, Zaribafian M. A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration. Neurol Int. 2019;11:9\u201311.","journal-title":"Neurol Int"},{"key":"3304_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0150-9861(06)77244-3","volume":"33","author":"O Kitis","year":"2006","unstructured":"Kitis O, Tekgul H, Erdemir G, Polat M, Serdaroglu G, Tosun A, Coker M, Gokben S. Identification of axonal involvement in Hallervorden-Spatz disease with magnetic resonance spectroscopy. J Neuroradiol. 2006;33:129\u201332.","journal-title":"J Neuroradiol"},{"key":"3304_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/0971-3026.69353","volume":"20","author":"UC Parashari","year":"2010","unstructured":"Parashari UC, Aga P, Parihar A, Singh R, Joshi V. Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration. Indian J Radiol Imaging. 2010;20:188.","journal-title":"Indian J Radiol Imaging"},{"key":"3304_CR18","first-page":"1690","volume":"24","author":"RN Sener","year":"2003","unstructured":"Sener RN. Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings. Am J Neuroradiol. 2003;24:1690\u20133.","journal-title":"Am J Neuroradiol"},{"key":"3304_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/nbm.698","volume":"14","author":"SW Provencher","year":"2001","unstructured":"Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260\u20134.","journal-title":"NMR Biomed"},{"key":"3304_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2005.04.035","volume":"384","author":"N Ackl","year":"2005","unstructured":"Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett. 2005;384:23\u20138.","journal-title":"Neurosci Lett"},{"key":"3304_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.pnpbp.2004.08.013","volume":"28","author":"BD Frederick","year":"2004","unstructured":"Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1313\u201322.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3304_CR22","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.neurobiolaging.2007.03.002","volume":"29","author":"J Oberg","year":"2008","unstructured":"Oberg J, Spenger C, Wang FH, Andersson A, Westman E, Skoglund P, Sunnemark D, Norinder U, Klason T, Wahlund LO, Lindberg M. Age related changes in brain metabolites observed by 1H MRS in APP\/PS1 mice. Neurobiol Aging. 2008;29:1423\u201333.","journal-title":"Neurobiol Aging"},{"key":"3304_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/nbm.1305","volume":"22","author":"N Kickler","year":"2009","unstructured":"Kickler N, Lacombe E, Chassain C, Durif F, Krainik A, Farion R, Provent P, Segebarth C, R\u00e9my C, Savasta M. Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo (1)H MRS study. NMR Biomed. 2009;22:207\u201312.","journal-title":"NMR Biomed"},{"key":"3304_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/nbm.3045","volume":"26","author":"S Ramadan","year":"2013","unstructured":"Ramadan S, Lin A, Stanwell P. Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed. 2013;26:1630\u201346.","journal-title":"NMR Biomed"},{"key":"3304_CR25","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00330-004-2553-4","volume":"15","author":"M H\u00e1jek","year":"2005","unstructured":"H\u00e1jek M, Adamovi\u010dov\u00e1 M, Herynek V, \u0160koch A, J\u00edr\u016f F, K\u0159epelov\u00e1 A, Dezortov\u00e1 M. MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Eur Radiol. 2005;15:1060\u20138.","journal-title":"Eur Radiol"},{"key":"3304_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2015.12.004","volume":"87","author":"C Bettencourt","year":"2016","unstructured":"Bettencourt C, Forabosco P, Wiethoff S, Heidari M, Johnstone DM, Bot\u00eda JA, Collingwood JF, Hardy J, Milward EA, Ryten M, Houlden H, (UKBEC), U. B. E. C. Gene co-expression networks shed light into diseases of brain iron accumulation. Neurobiol Dis. 2016;87:59\u201368.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3304_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/hmg\/ddi005","volume":"14","author":"YM Kuo","year":"2005","unstructured":"Kuo YM, Duncan JL, Westaway SK, Yang H, Nune G, Xu EY, Hayflick SJ, Gitschier J. Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Mol Genet. 2005;14(1):49\u201357. https:\/\/doi.org\/10.1093\/hmg\/ddi005 (Epub 2004 Nov 3).","journal-title":"Hum Mol Genet."},{"issue":"7","key":"3304_CR28","doi-asserted-by":"publisher","first-page":"e40871","DOI":"10.1371\/journal.pone.0040871","volume":"7","author":"M Garcia","year":"2012","unstructured":"Garcia M, Leonardi R, Zhang YM, Rehg JE, Jackowski S. Germline deletion of pantothenate kinases 1 and 2 reveals the key roles for CoA in postnatal metabolism. PLoS ONE. 2012;7(7):e40871. https:\/\/doi.org\/10.1371\/journal.pone.0040871 (Epub 2012 Jul 17).","journal-title":"PLoS ONE"},{"key":"3304_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.parkreldis.2015.03.009","volume":"21","author":"P Stoeter","year":"2015","unstructured":"Stoeter P, Roa-Sanchez P, Speckter H, Perez-Then E, Foerster B, Vilchez C, Oviedo J, Rodriguez-Raecke R. Changes of cerebral white matter in patients suffering from pantothenate kinase-associated neurodegeneration (PKAN): a diffusion tensor imaging (DTI) study. Parkinsonism Relat Disord. 2015;21:577\u201381.","journal-title":"Parkinsonism Relat Disord"},{"key":"3304_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"A Dorr","year":"2008","unstructured":"Dorr A, Lerch JP, Spring S, Kabani N, Henkelman RM. High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. Neuroimage. 2008;42:60\u20139.","journal-title":"Neuroimage"},{"key":"3304_CR31","first-page":"225","volume":"15","author":"GJ Harris","year":"1994","unstructured":"Harris GJ, Barta PE, Peng LW, Lee S, Brettschneider PD, Shah A, Henderer JD, Schlaepfer TE, Pearlson GD. MR volume segmentation of gray matter and white matter using manual thresholding: dependence on image brightness. AJNR Am J Neuroradiol. 1994;15:225\u201330.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3304_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ymgme.2015.10.012","volume":"116","author":"RL Woltjer","year":"2015","unstructured":"Woltjer RL, Reese LC, Richardson BE, Tran H, Green S, Pham T, Chalupsky M, Gabriel I, Light T, Sanford L. Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus. Mol Genet Metab. 2015;116:289\u201397.","journal-title":"Mol Genet Metab"},{"key":"3304_CR33","doi-asserted-by":"publisher","first-page":"32594","DOI":"10.1074\/jbc.M506275200","volume":"280","author":"Y-M Zhang","year":"2005","unstructured":"Zhang Y-M, Rock CO, Jackowski S. Feedback regulation of murine pantothenate kinase 3 by coenzyme A and coenzyme A thioesters. J Biol Chem. 2005;280:32594\u2013601.","journal-title":"J Biol Chem"},{"key":"3304_CR34","doi-asserted-by":"publisher","first-page":"27984","DOI":"10.1074\/jbc.M701915200","volume":"282","author":"BS Hong","year":"2007","unstructured":"Hong BS, Senisterra G, Rabeh WM, Vedadi M, Leonardi R, Zhang Y-M, Rock CO, Jackowski S, Park H-W. Crystal structures of human pantothenate kinases: insights into allosteric regulation and mutations linked to a neurodegeneration disorder. J Biol Chem. 2007;282:27984\u201393.","journal-title":"J Biol Chem"},{"key":"3304_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ymgme.2016.11.004","volume":"120","author":"P Hogarth","year":"2017","unstructured":"Hogarth P, Kurian MA, Gregory A, Cs\u00e1nyi B, Zagustin T, Kmiec T, Wood P, Klucken A, Scalise N, Sofia F. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN). Mol Genet Metab. 2017;120:278\u201387.","journal-title":"Mol Genet Metab"},{"key":"3304_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jnnp.2008.169953","volume":"80","author":"SA Schneider","year":"2009","unstructured":"Schneider SA, Hardy J, Bhatia K. Iron accumulation in syndromes of neurodegeneration with brain iron accumulation 1 and 2: causative or consequential? J Neurol Neurosurg Psychiatry. 2009;80:589\u201390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3304_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4081\/ni.2018.7516","volume":"10","author":"S Razmeh","year":"2018","unstructured":"Razmeh S, Habibi AH, Orooji M, Alizadeh E, Moradiankokhdan K, Razmeh B. Pantothenate kinase-associated neurodegeneration: clinical aspects, diagnosis and treatments. Neurol Int. 2018;10:32\u20134.","journal-title":"Neurol Int"},{"key":"3304_CR38","doi-asserted-by":"publisher","first-page":"e10489","DOI":"10.15252\/emmm.201910489","volume":"11","author":"SY Jeong","year":"2019","unstructured":"Jeong SY, Hogarth P, Placzek A, Gregory AM, Fox R, Zhen D, Hamada J, van der Zwaag M, Lambrechts R, Jin H, Nilsen A, Cobb J, Pham T, Gray N, Ralle M, Duffy M, Schwanemann L, Rai P, Freed A, Wakeman K, Woltjer RL, Sibon OC, Hayflick SJ. 4\u2032-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN. EMBO Mol Med. 2019;11:e10489.","journal-title":"EMBO Mol Med"},{"key":"3304_CR39","doi-asserted-by":"publisher","first-page":"117906951985111","DOI":"10.1177\/1179069519851118","volume":"13","author":"S Jackowski","year":"2019","unstructured":"Jackowski S. Proposed therapies for pantothenate-kinase-associated neurodegeneration. J Exp Neurosci. 2019;13:1179069519851118.","journal-title":"J Exp Neurosci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03304-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:12:22Z","timestamp":1645621942000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03304-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3304"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03304-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was limited to animals, and the statement mentioning the study protocol bein approved by an institutional ethics committee is already present in the Methods section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SJ is a member of the Scientific Advisory Board of CoA Therapeutics, Inc. SJ, COR and CS are co-inventors of the patent #US2021\/0061788. Other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}